Navigation Links
DMC Cardiovascular Institute First in Midwest to Implant New "Protecta" Defibrillator in a Cardiac Patient
Date:4/5/2011

DETROIT, April 5, 2011 /PRNewswire-USNewswire/ -- The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) announced today that it has achieved a significant breakthrough in cardiac heart-care by implanting the newly available "Protecta" defibrillator in a heart-care patient.

The successful procedure, which took place at the DMC March 30, marked the first time that the innovative Protecta device has been implanted in a cardiac patient anywhere in the Midwest.        

The Protecta defibrillator, approved for clinical use by the U.S. Food and Drug Administration (FDA) only eight days ago, is designed to greatly reduce the inappropriate electrical shocks that can occur with traditional defibrillators – often in situations where patients are located near electrical currents or electrical equipment.

According to recent medical research, more than 20 percent of heart-care patients who are outfitted with defibrillators experience such inappropriate shocks at times.  But the new high-tech Protecta was specially designed to virtually eliminate such unwanted electrical impulses in most patients.

Implanted defibrillators are a vital necessity for many heart-care patients who struggle with arrhythmias, since these irregular heartbeats – caused by interruptions in normal electrical heart-signaling – can trigger sudden cardiac death in severe cases.  (More than 350,000 Americans die from these sudden heart attacks each year.)  In the past, however, even the most effective defibrillators often subjected their owners to inappropriate shocks that can interfere with the defibrillation process.

But the successful implantation of the new Protecta at CVI now means that patients who require a defibrillator in order to guard against arrhythmia can also be protected against such accidental shocks.          

.  

"For patients with heartbeat issues that require an implanted defibrillator, this new technology is an important breakthrough," said Randy A. Lieberman, M.D., the Director of Electrophysiology at CVI.  "Our goal at CVI is to keep improving the quality of life for those who need implanted defibrillators, and this pioneering device is a major step on the road to accomplishing that.

"This is a proven technology, FDA-approved, that's been shown to be very effective at eliminating unnecessary shocks.  It's also brand-new – and we were very pleased to learn that we were the first heart-care facility in the entire Midwest to make it available to patents.

"At CVI, we're determined to provide cardiac patients with the very latest heart-care technology.  We want to prolong life with these exciting new tools, that's true – but we also want to improve the quality of life at the same time.  The new Protecta implantable defibrillator is an important step in accomplishing both of those goals."

Dr. Lieberman, who conducted the successful Protecta implantation at DMC Harper University Hospital's Cardiovascular Institute last week, also noted that CVI was recently the first heart-care facility in Michigan to accomplish a transcatheter aortic valve implant, back in February.  That ground-breaking procedure was led by CVI President Theodore L. Schreiber, M.D. and Dr. Ali Kafi, chief of clinical cardio-thoracic surgery at DMC Harper University Hospital.  They were accompanied by a multidisciplinary team of DMC physicians, nurses, research team and technologists.

Describing the recent breakthrough implantation of the Protecta defibrillator, Dr. Schreiber said, "This is certainly a significant treatment advance for patients who need an implanted defibrillator, and it's a very encouraging step forward in helping improve their quality of life."

Added Dr. Schreiber, who was a pioneer in developing the stent procedure for relieving blocked carotid arteries and who currently performs about 1,500 heart and vascular procedures per year at the DMC:  "We're very determined at CVI to bring patients the very latest, cutting-edge heart-care technologies, and it's gratifying to know that we're now able to make Protecta available to any patient who might benefit from it."

Physicians are available for interviews.

For more information, visit www.DMCCVI.org.

About Detroit Medical Center www.dmc.org

The Detroit Medical Center operates nine hospitals and institutes, including Children's Hospital of Michigan, Detroit Receiving Hospital, Harper University Hospital, Huron Valley-Sinai Hospital, Hutzel Women's Hospital, Rehabilitation Institute of Michigan, Sinai-Grace Hospital, DMC Surgery Hospital, and DMC Cardiovascular Institute. The Detroit Medical Center is a leading regional healthcare system with a mission of excellence in clinical care, research and medical education.


'/>"/>
SOURCE Detroit Medical Center
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Medstreaming Launches Fully Integrated Cardiovascular PACS and Certified EMR With Electronic Whiteboard at ACC
2. Siemens Demonstrates Strategy for Sustainable Cardiovascular Care
3. Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits
4. NewCardio Invited to Present Latest QTinno Performance Improvements at FDA-Sponsored Conference on Cardiovascular Safety in Drug Development
5. Terumo Cardiovascular Systems Reaches Agreement on Terms of Consent Decree With FDA Regarding Quality System Improvements
6. Fujifilms Exclusive Software Advances Cardiovascular Reporting Capabilities
7. Medtronic Inc. Cancels Cardiovascular and Orthopedic Contracts With Novation
8. Reportlinker Adds Product Pipeline in Medical Equipment Market - Robust Pipeline Strengthening the In-Vitro Diagnostics and Cardiovascular Devices Market
9. MAQUET Cardiovascular Launches New VASOVIEW 6 PRO Endoscopic Vessel Harvesting System
10. CardioVascular BioTherapeutics Submits FDA Application for Fast Track Status for CVBT-141B, CVBTs Biological Treatment for Diabetes Patients
11. Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardiovascular Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... 2016 Dr. Vivek Ahuja , ... Ste phen Schmidt ... provider of cloud-based software solutions for life sciences, today announced key ... a wealth of insight to a growing business.  This will bolster ... George Phillips joined ArisGlobal in the position of Vice ...
(Date:4/28/2016)... April 28, 2016   Acsis , a leading ... leading IT market research and advisory firm IDC has ... IDC MarketScape: Worldwide Pharmaceutical Track and Trace Software 2016 ... provides an assessment of the capabilities and business strategies ... software market. Logo - http://photos.prnewswire.com/prnh/20160427/360791LOGO ...
(Date:4/28/2016)... 2016 TapImmune,Inc. (TPIV), a ... and gene-based immunotherapeutics and vaccines for the treatment of cancer ... the 3rd Annual Growth Capital Expo to be ... at Caesars Palace in Las Vegas, Nevada.  The Company ... 4 th by Dr. John N. Bonfiglio ...
Breaking Medicine Technology:
(Date:4/29/2016)... ... April 29, 2016 , ... Shamangelic Healing, Sedona ... Onnit brand Alpha BRAIN and New Mood Daily-Stress Formula for brain optimization and ... products to the store is just one more way Shamangelic Healing supports people’s ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... ... advocating optimistic healthcare awareness and author of best seller "LOVE, MEDICINE and MIRACLES") ... Radio Monday, May 2, 2016 and podcasted thereafter . Dr. Bernie Siegel, ...
(Date:4/29/2016)... Fla. (PRWEB) , ... April 29, 2016 , ... ... Hospital surgeon reveals that infants born with severe congenital diaphragmatic hernia have better ... is born with congenital diaphragmatic hernia (CDH)—a condition where the diaphragm fails to ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... patented products, announces the Gyrociser, an exercise invention which aids in proper muscle ... says Scott Cooper, CEO and Creative Director of World Patent Marketing. "Globalization has ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):